Iopromide is a radiographic contrast agent indicated for use as an X-ray contrast agent in the following procedures intra-arterial digital subtraction angiography (IA-DSA), cerebral arteriography and peripheral arteriography, coronary arteriography and left ventriculography, visceral angiography and aortography, peripheral venography, excretory urography, and contrast computed tomography (CT) imaging of head and body. Iopromide is a nonionic, water soluble, tri-iodinated x-ray contrast agent. Following IV injection, the vessels in the path of its flow are opacified. This permits radiographic visualization of the internal structures until significant hemodilution occurs.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Iopromide, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.